Skip to main content

Table 3 Parameter estimates (analogous to Table 2) for the regression analyses for the subgroups of “true placebos” and “ICS-placebos”

From: Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression

Parameter

Estimate

Implied annual percentage change

Pb

True placebos (21 studies):

 Rate intercept β0

0.440 (− 0.034, 0.912)

  

 Rate slope β1 (publication year)

−0.079 (− 0.132, − 0.026)

− 7.553 (− 12.356, − 2.606)

0.006

 Rate random effect σλ

0.517 (0.356, 0.787)

  

 Overdispersion mean μφ

−5.139 (− 9.011, − 0.708)

  

 Overdispersion random effect σφ

0.667 (0.031, 2.263)

  

ICS-placebos (34 studies):

 Rate intercept β0

0.440 (−0.034, 0.912)

  

 Rate slope β1 (publication year)

−0.079 (− 0.132, − 0.026)

−7.553 (− 12.356, − 2.606)

<  0.001

 Rate random effect σλ

0.517 (0.356, 0.787)

  

 Overdispersion mean μφ

−5.139 (− 9.011, − 0.708)

  

 Overdispersion random effect σφ

0.667 (0.031, 2.263)